ENSG:NGS-The Ensign Group Inc. (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 132.87

Change

+0.01 (+0.01)%

Market Cap

USD 1.10B

Volume

0.40M

Analyst Target

USD 62.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ensign Group Inc offers skilled nursing & rehabilitative care services in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Oregon, Texas & Washington.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-02 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ACHC Acadia Healthcare Company Inc

N/A

USD 4.12B
OPCH Option Care Health Inc

N/A

USD 4.00B
AMED Amedisys Inc

N/A

USD 2.99B
LFST Lifestance Health Group Inc

N/A

USD 2.74B
SGRY Surgery Partners Inc

N/A

USD 2.68B
ADUS Addus HomeCare Corporation

N/A

USD 2.26B
ASTH Astrana Health Inc

N/A

USD 1.47B
AVAH Aveanna Healthcare Holdings In..

N/A

USD 0.88B
HCSG Healthcare Services Group Inc

N/A

USD 0.84B
CCRN Cross Country Healthcare Inc

N/A

USD 0.59B

ETFs Containing ENSG

OASC OneAscent Small Cap Core .. 0.88 % 0.00 %

N/A

USD 0.02B
CBUSAS:SW Amundi S&P SmallCap 600 E.. 0.85 % 0.00 %

N/A

N/A
RTWO:LSE L&G Russell 2000 US Small.. 0.55 % 0.00 %

N/A

USD 0.23B
RTWP:LSE Legal & General UCITS ETF.. 0.55 % 0.00 %

N/A

USD 0.23B
IWO iShares Russell 2000 Grow.. 0.00 % 0.24 %

N/A

N/A
JSMD Janus Henderson Small/Mid.. 0.00 % 0.50 %

N/A

USD 0.42B
OLD 0.00 % 0.50 %

N/A

N/A
OSCV Opus Small Cap Value Plus 0.00 % 0.79 %

N/A

USD 0.47B
KSCD 0.00 % 0.00 %

N/A

N/A
VRTGX Vanguard Russell 2000 Gro.. 0.00 % 0.00 %

N/A

USD 1.19B
VRTIX Vanguard Russell 2000 Ind.. 0.00 % 0.00 %

N/A

USD 10.02B
SLY 0.00 % 0.15 %

N/A

N/A
SLYG SPDR® S&P 600 Small Cap .. 0.00 % 0.15 %

N/A

N/A
VIOO Vanguard S&P Small-Cap 60.. 0.00 % 0.15 %

N/A

N/A
IDP6:LSE iShares S&P SmallCap 600 .. 0.00 % 0.00 %

N/A

N/A
IUS3:F iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

N/A
ETLZ:XETRA L&G Russell 2000 US Small.. 0.00 % 0.00 %

N/A

USD 0.09B
IUS3:XETRA iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

N/A
SMLE 0.00 % 0.00 %

N/A

N/A
DFAS Dimensional U.S. Small Ca.. 0.00 % 0.00 %

N/A

USD 9.79B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.01% 38% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.01% 38% F 46% F
Trailing 12 Months  
Capital Gain 16.72% 81% B- 71% C-
Dividend Return 0.27% 100% F 3% F
Total Return 16.98% 81% B- 69% C-
Trailing 5 Years  
Capital Gain 193.25% 90% A- 92% A
Dividend Return 2.59% 50% F 7% C-
Total Return 195.83% 90% A- 92% A
Average Annual (5 Year Horizon)  
Capital Gain 29.64% 74% C 80% B-
Dividend Return 29.93% 74% C 79% B-
Total Return 0.29% 50% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 39.67% 52% F 48% F
Risk Adjusted Return 75.45% 100% F 89% A-
Market Capitalization 1.10B 100% F 91% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.30 41% 29%
Price/Book Ratio 4.63 13% 27%
Price / Cash Flow Ratio 21.91 16% 14%
Price/Free Cash Flow Ratio 23.82 25% 16%
Management Effectiveness  
Return on Equity 14.96% 100% 85%
Return on Invested Capital 12.65% 89% 81%
Return on Assets 4.02% 68% 82%
Debt to Equity Ratio 9.75% 71% 72%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.